Events Preceding Interstitial Cystitis (EPIC) (EPIC)
|ClinicalTrials.gov Identifier: NCT00248664|
Recruitment Status : Completed
First Posted : November 4, 2005
Last Update Posted : March 3, 2010
|Condition or disease|
This project is a systematic, national study of incident IC cases and controls matched by age and gender. By telephone interview and medical record review, we compare exposures of cases and controls seeking significant differences which may be risk factors for IC. This cohort of incident IC cases will initiate a natural history study of the disease.
Specific Aim 1. To test the hypothesis that certain features that precede onset of IC symptoms, e.g., bacterial cystitis, distinguish IC cases from controls matched for age and gender, and may be risk factors for the disease.
Specific Aim 2. To test the hypotheses that patients with IC have higher prevalences of certain non bladder syndromes, e.g., irritable bowel syndrome, than do controls matched for age and gender.
Specific Aim 3. To test the hypothesis that urine APF, HB EGF, and/or EGF are sensitive and specific diagnostic markers for IC in patients with symptoms of ÿ12 months.
Specific Aim 4. To test the hypotheses that, in an incident cohort, patients with IC have remissions and that certain clinical features, e.g., bacterial cystitis at disease onset, are prognostic factors for remissions.
|Study Type :||Observational|
|Estimated Enrollment :||400 participants|
|Official Title:||A Case Control Study of Interstitial Cystitis|
|Study Start Date :||March 2004|
|Actual Study Completion Date :||November 2008|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00248664
|United States, Maryland|
|University of Maryland School of Medicine|
|Baltimore, Maryland, United States, 21201|
|Principal Investigator:||John W Warren, MD||University of Maryland|